VERSANT VENTURE CAPITAL VI, L.P. sold 18.2% of their position (1.13M shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.40M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2024ACC: 0000950170-24-109112
10% Owner
Since Jun 2021
-1.13M
Net shares
Net seller
$7.40M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.13M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.13M
Price / share
$6.53
Trade value
$7.40M
% of position
18.2%
9/20/2024
6.23M→5.10M
Total
Net shares
−1.13M
Net value
-$7.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/20/2024 | S · Sale | −1.13M | $6.53 | $7.40M | 18.2% | 6.23M | 5.10M |
| Total | −1.13M | -$7.40M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.10M
Total
2.10M indirect2.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.10M | Indirect |
| Total | 2.10M | 2.10M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported